Skip to main content

Table 2 Data assessment in the MS-VisualPath Cohort, Barcelona, Spain

From: The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS

 

Baseline

Year 1

Year 2

Year 3

Year 4

Year 5

EDSS and Annualized Relapse Rate

X

X

X

X

X

X

Multiple Sclerosis Functional Composite

X

X

X

X

 

X

Quality of Life (SF-36, NEI-VFQ-25 + 10S1)

X

  

X

 

X

Anxiety and Depression assessment1

X

  

X

 

X

Neuropsychological Battery (BRB-N)

X

 

X

  

X

High (EDTRS) and Low (LCSLC) VA

X

X

X

X

X

X

Color vision test (HRR plates)

X

X

X

X

X

X

Visual Fields

X

X

   

X

Indirect Funduscopy - Optomap2002

X

X

X

X

X

X

Multifocal Visual Evoked Potentials2

X

X

X

X

X

X

Optical Coherence Tomography

X

X

X

X

X

X

Magnetic Resonance Imaging

X

X

X

X

X

X

  1. Included in the protocol on 1 September 2013 and 2February, 2013. EDSS: Expanded Disability Status Scale; MSFC: SF-36: Short Form-36; NEI-VFQ-25 + 10S: 25-Item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and the 10-Item Neuro-Ophthalmic Supplement; BRB-N: Brief Repeatable Battery-Neuropsychology; EDTRS: Early Treatment for Diabetic Retinopathy Study; LCSLC: Low-Contrast Sloan Letter Chart; VA: Visual Acuity; HRR: Hardy Rand and Rittler.